Nephro Care India Limited Stock Price Today (NSE: NEPHROCARE)
Fundamental Score
Nephro Care India Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Nephro Care India Limited share price today is ₹68.85, up +0.00% on NSE/BSE as of 2 June 2026. Nephro Care India Limited (NEPHROCARE) is a Small-cap company in the Hospital sector with a market capitalisation of ₹220.67 (Cr). The 52-week high for NEPHROCARE share price is ₹183.00 and the 52-week low is ₹51.65. At a P/E ratio of 65.09x, NEPHROCARE is currently trading above its industry average P/E of 52.84x. The company has a Return on Equity (ROE) of 8.38% and a debt-to-equity ratio of 0.00.
Nephro Care India Limited Share Price Chart — NSE/BSE Historical Performance
Nephro Care India Limited share price chart: -7.06% return over the past month. 52-week high ₹183.00, 52-week low ₹51.65.
Nephro Care India Limited — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹80.00 | ₹83.10 | ₹79.00 | ₹80.25 | 16.00K (Cr) | |
| ₹80.00 | ₹83.80 | ₹78.00 | ₹78.40 | 30.00K (Cr) | |
| ₹85.00 | ₹85.00 | ₹78.35 | ₹79.55 | 22.00K (Cr) | |
| ₹88.00 | ₹88.00 | ₹85.35 | ₹87.00 | 8.80K (Cr) | |
| ₹80.80 | ₹83.40 | ₹80.55 | ₹82.85 | 13.20K (Cr) | |
| ₹80.50 | ₹81.95 | ₹80.00 | ₹80.55 | 3.20K (Cr) | |
| ₹87.50 | ₹88.90 | ₹86.15 | ₹88.60 | 21.60K (Cr) | |
| ₹86.35 | ₹88.90 | ₹86.00 | ₹86.35 | 7.20K (Cr) | |
| ₹55.90 | ₹58.50 | ₹53.00 | ₹58.25 | 15.60K (Cr) | |
| ₹59.00 | ₹59.00 | ₹51.65 | ₹52.30 | 1.11L (Cr) |
Nephro Care India Limited — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹80.50 | ₹88.00 | ₹78.00 | ₹80.25 | -0.31% | |
| ₹55.90 | ₹88.90 | ₹53.00 | ₹88.60 | +58.50% | |
| ₹63.50 | ₹63.50 | ₹51.65 | ₹52.30 | -17.64% | |
| ₹101.20 | ₹116.05 | ₹70.00 | ₹82.45 | -18.53% | |
| ₹112.25 | ₹123.00 | ₹95.00 | ₹100.20 | -10.73% | |
| ₹131.20 | ₹131.40 | ₹107.50 | ₹110.50 | -15.78% | |
| ₹131.95 | ₹156.35 | ₹131.95 | ₹148.00 | +12.16% | |
| ₹140.10 | ₹145.00 | ₹131.35 | ₹139.00 | -0.79% | |
| ₹154.00 | ₹173.95 | ₹133.55 | ₹142.85 | -7.24% | |
| ₹146.90 | ₹183.00 | ₹133.05 | ₹155.05 | +5.55% | |
| ₹117.20 | ₹150.00 | ₹99.95 | ₹145.35 | +24.02% | |
| ₹136.95 | ₹141.00 | ₹115.50 | ₹116.90 | -14.64% |
AI Research Briefing
Powered by Gemini · 2026-04-13
Expensive micro-cap dialysis play with GST risk; avoid until valuation becomes rational.
WHAT'S HAPPENING NOW (last 2-4 weeks)
Nephro Care is fighting a Cr GST bill in High Court after an appeal was blocked. A significant price movement was observed on April 9, 2026.
CORE STORY (THE REAL GAME)
- Sales CAGR 5Y of 143.29%
- InCred Securities initiated coverage with an 'ADD' rating and a target price of ₹613
- Asset-light model with 52% of clinics operating within partner hospitals and PPP clinics
- Significant order wins
- Successful resolution of GST issue
- Faster-than-expected expansion of dialysis centers
- Micro/SME cap - liquidity risk
- High P/E of 65.09x vs industry P/E of 52.84x [cite: brief]
- GST bill of ₹2.51 Cr
FII decreased holdings by 0.03%, DII decreased holdings by 1.2% [cite: brief].
Growing demand for healthcare services in India provides a tailwind.
No - Free Cash Flow 5Y: ₹-22.86 Cr [cite: brief]
3-6 month thesis: Expect a correction as valuation normalizes. Monitor for successful resolution of GST issue and execution of expansion plans.
Primary Thesis Risk
Overvaluation and reliance on government contracts create significant downside risk.
For educational purposes only. Not investment advice. Consult a SEBI-registered advisor before investing.
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Nephro Care India Limited Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Nephro Care India Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of NEPHROCARE across key market metrics for learning purposes.
Positive Indicators
9 factors identified
Strong Operating Margins (16.80%)
Observation: Healthy 5-year operating margins indicate pricing power and cost control.
Analysis: OPM >15% suggests operational efficiency and competitive advantages.
Strong Revenue Growth (122.33%)
Observation: Healthy sales growth indicates market demand and execution capability.
Analysis: Revenue growth >15% suggests strong market position and growth potential.
Consistent Growth Track Record (143.29% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Excellent EPS Growth (16.80% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (210.58% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Strong Interest Coverage (26.61x)
Observation: Earnings comfortably cover interest obligations.
Analysis: Interest coverage >5x indicates low financial distress risk.
Balanced Promoter Holding (61.47%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
6 factors identified
Below-Average Return on Equity (8.38%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Premium Valuation Risk (P/E: 65.09x)
Observation: High valuation multiples may limit upside potential.
Analysis: Elevated P/E ratios require strong growth execution to justify current valuations.
Profit Decline Concern (-11.42%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Negative Free Cash Flow (₹-22.86 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 4.51%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Nephro Care India Limited vs Hospital Peers
Peer Comparison - Hospital
Compare Nephro Care India Limited with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
57.1/100 | ₹68.85₹69 | ₹220.67₹220.67 | 65.09Average 65.1 Average | 8.38%Poor 8.38% Poor | 11.27%Average 11.27% Average | 0.00Excellent 0.0 Excellent | 210.58%Excellent 210.58% Excellent | 143.29%Excellent 143.29% Excellent | 0.00% | |
Max Healthcare Institute LtdMax Healthcare ... MAXHEALTH • 543220 | 69.1/100 | ₹993.45₹993 | ₹109416.28₹109416.28 | 77.65Average 77.7 Average | 12.72%Average 12.72% Average | 14.88%Average 14.88% Average | 0.33Excellent 0.3 Excellent | 80.50%Excellent 80.50% Excellent | 46.01%Excellent 46.01% Excellent | 0.13% |
Apollo Hospitals Enterprise LtdApollo Hospital... APOLLOHOSP • 508869 | 50.2/100 | ₹8272.50₹8273 | ₹104825.94₹104825.94 | 62.70Average 62.7 Average | 18.42%Good 18.42% Good | 16.64%Good 16.64% Good | 0.88Good 0.9 Good | 33.72%Excellent 33.72% Excellent | 14.15%Good 14.15% Good | 0.26% |
Fortis Healthcare LtdFortis Healthca... FORTIS • 532843 | 55.6/100 | ₹960.90₹961 | ₹68301.24₹68301.24 | 67.80Average 67.8 Average | 10.13%Average 10.13% Average | 11.96%Average 11.96% Average | 0.34Excellent 0.3 Excellent | 70.31%Excellent 70.31% Excellent | 10.93%Good 10.93% Good | 0.11% |
Narayana Hrudayalaya LtdNarayana Hruday... NH • 539551 | 62.2/100 | ₹1920.20₹1920 | ₹39051.19₹39051.19 | 45.92Average 45.9 Average | 24.22%Excellent 24.22% Excellent | 20.75%Excellent 20.75% Excellent | 0.58Good 0.6 Good | 43.49%Excellent 43.49% Excellent | 11.88%Good 11.88% Good | 0.24% |
Aster DM Healthcare LtdAster DM Health... ASTERDM • 540975 | 15.4/100 | ₹741.25₹741 | ₹34688.15₹34688.15 | 94.51Average 94.5 Average | 8.26%Poor 8.26% Poor | 10.68%Average 10.68% Average | 0.46Excellent 0.5 Excellent | -7.24%Poor -7.24% Poor | -13.71%Poor -13.71% Poor | 0.75% |
Global Health LtdGlobal Health L... MEDANTA • 543654 | 61/100 | ₹1207.80₹1208 | ₹33498.00₹33498.00 | 56.03Average 56.0 Average | 16.48%Good 16.48% Good | 19.74%Good 19.74% Good | 0.25Excellent 0.3 Excellent | 70.15%Excellent 70.15% Excellent | 19.73%Excellent 19.73% Excellent | 0.04% |
45.1/100 | ₹784.45₹784 | ₹27605.54₹27605.54 | 83.99Average 84.0 Average | 18.48%Good 18.48% Good | 15.00%Good 15.00% Good | 1.40Average 1.4 Average | 25.01%Excellent 25.01% Excellent | 22.01%Excellent 22.01% Excellent | 0.00% | |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 51.2/100 | ₹479.95₹480 | ₹16844.04₹16844.04 | 145.15Average 145.2 Average | 4.76%Poor 4.76% Poor | 9.99%Poor 9.99% Poor | 0.51Good 0.5 Good | 41.72%Excellent 41.72% Excellent | 26.38%Excellent 26.38% Excellent | 0.00% |
Rainbow Childrens Medicare Pvt LtdRainbow Childre... RAINBOW • 543524 | 54.6/100 | ₹1377.10₹1377 | ₹13410.38₹13410.38 | 52.84Average 52.8 Average | 17.43%Good 17.43% Good | 18.69%Good 18.69% Good | 0.54Good 0.5 Good | 33.66%Excellent 33.66% Excellent | 16.08%Excellent 16.08% Excellent | 0.23% |
36.4/100 | ₹659.95₹660 | ₹10474.40₹10474.40 | 296.22Average 296.2 Average | 5.14%Poor 5.14% Poor | 8.56%Poor 8.56% Poor | 1.92Average 1.9 Average | 19.34%Excellent 19.34% Excellent | 15.22%Excellent 15.22% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Max Healthcare Institute Ltd share price109416.28 Cr
- Apollo Hospitals Enterprise Ltd share price104825.94 Cr
- Fortis Healthcare Ltd share price68301.24 Cr
- Narayana Hrudayalaya Ltd share price39051.19 Cr
- Aster DM Healthcare Ltd share price34688.15 Cr
Nephro Care India Limited PE Ratio History
Historical price-to-earnings ratio for NEPHROCARE — last 5 years
| Year | EPS (₹) | Price (₹) | P/E Ratio |
|---|---|---|---|
| FY 2024 | ₹2.73 | ₹184.00 | 67.4x |
P/E = year-end price ÷ diluted EPS from annual filings. Source: NSE/BSE via Bull Run.
Nephro Care India Limited Quarterly Performance
Latest quarterly metrics for NEPHROCARE — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
122.33%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-11.42%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
143.29%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
210.58%
Compounded annual net profit growth over 5 years
Nephro Care India Limited Technical Indicators
SMA 50, SMA 200, RSI and volume signals for NEPHROCARE — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Nephro Care India Limited Financial Statements
Annual income statement, balance sheet and cash flow for Nephro Care India Limited (NEPHROCARE) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Nephro Care India Limited
About NEPHROCARE (Nephro Care India Limited)
Nephro Care India Limited (NEPHROCARE) is listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) of India. The company operates in the Hospital sector with a c...urrent market capitalisation of ₹220.67 (Cr). Nephro Care India Limited has delivered a Return on Equity (ROE) of 8.38% and a ROCE of 11.27%. The debt-to-equity ratio stands at 0.00, reflecting the company's capital structure. Investors tracking NEPHROCARE share price can monitor key metrics including P/E ratio, promoter holding of 61.47%, and quarterly earnings growth.
Company Details
NEPHROCARE Share Price: Frequently Asked Questions
What is the current share price of Nephro Care India Limited?
Nephro Care India Limited (NEPHROCARE) trades at ₹68.85 on NSE. Market cap ₹220.67 (Cr). Educational data only.
What is the P/E ratio of Nephro Care India Limited?
Nephro Care India Limited has a P/E of 65.09x vs industry average 52.84x.
What is the Bull Run score for Nephro Care India Limited?
Nephro Care India Limited has a Bull Run score of 57.1/100 based on 25+ financial parameters.
Does Nephro Care India Limited pay dividends?
Nephro Care India Limited has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Nephro Care India Limited?
Nephro Care India Limited has ROE of 8.38%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Nephro Care India Limited?
Nephro Care India Limited has debt-to-equity of 0.00.
Is Nephro Care India Limited a good investment?
Bull Run gives Nephro Care India Limited a score of 57.1/100. This is not investment advice — consult a SEBI-registered advisor.